Ventricular septal defects

References

Key articles

Stout KS, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 Apr 2;139(14):e698-800.Full text  Abstract

Sable C, Foster E, Uzark K, et al. Best practices in managing transition to adulthood for adolescents with congenital heart disease: the transition process and medical and psychosocial issues: a scientific statement from the American Heart Association. Circulation. 2011 Apr 5;123(13):1454-85.Full text  Abstract

Beghetti M, Galiè N. Eisenmenger syndrome: a clinical perspective in a new therapeutic era of pulmonary hypertension. J Am Coll Cardiol. 2009 Mar 3;53(9):733-40. Abstract

Barst RJ, Ivy DD, Gaitan G, et al. A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension. Circulation. 2012 Jan 17;125(2):324-34. Abstract

Reference articles

1. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in collaboration with the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008 Dec 2;52(23):e143-263.Full text  Abstract

2. Stout KS, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 Apr 2;139(14):e698-800.Full text  Abstract

3. Lopez L, Houyel L, Colan SD, et al. Classification of ventricular septal defects for the eleventh iteration of the International Classification of Diseases-Striving for Consensus: a report from the International Society for Nomenclature of Paediatric and Congenital Heart Disease. Ann Thorac Surg. 2018 Nov;106(5):1578-89. Abstract

4. Brickner ME, Hillis DL, Lange RA. Congenital heart disease in adults: first of two parts. N Engl J Med. 2000 Jan 27;342(4):256-63. Abstract

5. Perloff JK. Survival patterns without cardiac surgery or interventional catheterization: a narrowing base. In: Perloff JK, Childs JS, eds. Congenital heart disease in adults. 2nd ed. Philadelphia, PA: WB Saunders; 1998:15-53.

6. Graham TP Jr, Gutgesell HP. Ventricular septal defects. In: Emmanouilides GC, Riemenschneider TA, Allen HD, Gutgesell HP, eds. Moss and Adams heart disease in infants, children, and adolescents. Baltimore, MD: Williams & Wilkins, 1995:724-46.

7. Craig B. Atrioventricular septal defect: from fetus to adult. heart. 2006 Dec;92(12):1879-85. Abstract

8. Tubman RJ, Shields MD, Craig BG, et al. Congenital heart disease in Down's syndrome: two year prospective early screening study. BMJ. 1991 Jun 15;302(6790):1425-7. Abstract

9. Reller MD, Strickland MJ, Riehle-Colarusso, et al. Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Paediatr. 2008 Dec;153(6):807-13. Abstract

10. Libby P, Bonow RO. Braunwald's heart disease: a textbook of cardiovascular medicine. 8th ed. London, UK: WB Saunders; 2008.

11. Birnbaum Y, Fishbein MC, Blanche C, et al. Ventricular septal defect after acute myocardial infarction. New Engl J Med. 2002 Oct 31;347(18):1426-32. Abstract

12. Burd L, Deal E, Rios R, et al. Congenital heart disease and fetal alcohol spectrum disorders. Congenit Heart Dis. 2007 Jul-Aug;2(4):250-5. Abstract

13. Fuster V, Walsh RA, O'Rourke RA, et al. Hurst's the heart, 12th edition. New York, NY: McGraw-Hill; 2007.

14. Magee AG, Boutin C, McCrindle BW, et al. Echocardiography and cardiac catheterization in the preoperative assessment of ventricular septal defect in infancy. Am Heart J. 1998 May;135(5 Pt 1):907-13. Abstract

15. American College of Radiology. ACR Appropriateness Criteria: known or suspected congenital heart disease in the adult. 2016. [internet publication].Full text

16. Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC guidelines for the management of adult congenital heart disease. Eur Heart J. 2020 Aug 29;ehaa554.Full text  Abstract

17. Sable C, Foster E, Uzark K, et al. Best practices in managing transition to adulthood for adolescents with congenital heart disease: the transition process and medical and psychosocial issues: a scientific statement from the American Heart Association. Circulation. 2011 Apr 5;123(13):1454-85.Full text  Abstract

18. Yang J, Yang L, Yu S, et al. Transcatheter versus surgical closure of perimembranous ventricular septal defects in children: a randomized controlled trial. J Am Coll Cardiol. 2014 Apr 1;63(12):1159-68.Full text  Abstract

19. Szkutnik M, Qureshi SA, Kusa J, et al. Use of the Amplatzer muscular ventricular septal defect occluder for closure of perimembranous ventricular septal defects. Heart. 2007 Mar;93(3):355-8. Abstract

20. Masura J, Gao W, Gavora P, et al. Percutaneous closure of perimembranous ventricular septal defects with the eccentric Amplatzer device: multicenter follow-up study. Pediatr Cardiol. 2005 May-Jun;26(3):216-9. Abstract

21. Fu YC, Bass J, Amin Z, et al. Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: results of the U.S. phase I trial. J Am Coll Cardiol. 2006 Jan 17;47(2):319-25. Abstract

22. Butera G, Carminati M, Chessa M, et al. Transcatheter closure of perimembranous ventricular septal defects: early and long-term results. J Am Coll Cardiol. 2007 Sep 18;50(12):1189-95. Abstract

23. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239.Full text  Abstract

24. Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017 Aug 8;136(6):e137-61.Full text  Abstract

25. Beghetti M, Galiè N. Eisenmenger syndrome: a clinical perspective in a new therapeutic era of pulmonary hypertension. J Am Coll Cardiol. 2009 Mar 3;53(9):733-40. Abstract

26. Galiè N, Beghetti M, Gatzoulis MA, et al. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Circulation. 2006 Jul 4;114(1):48-54. Abstract

27. Chau EM, Fan KY, Chow WH. Effects of chronic sildenafil in patients with Eisenmenger syndrome versus idiopathic pulmonary arterial hypertension. Int J Cardiol. 2007 Sep 3;120(3):301-5. Abstract

28. Fernandes SM, Newburger JW, Lang P, et al. Usefulness of epoprostenol therapy in the severely ill adolescent/adult with Eisenmenger physiology. Am J Cardiol. 2003 Mar 1;91(5):632-5. Abstract

29. Barst RJ, Ivy DD, Gaitan G, et al. A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension. Circulation. 2012 Jan 17;125(2):324-34. Abstract

30. Waddell TK, Bennett L, Kennedy R, et al. Heart-lung or lung transplantation for Eisenmenger syndrome. J Heart Lung Transplant. 2002 Jul;21(7):731-7. Abstract

31. Stoica SC, McNeil KD, Perreas K, et al. Heart-lung transplantation for Eisenmenger syndrome: early and long-term results. Ann Thorac Surg. 2001 Dec;72(6):1887-91. Abstract

32. Perrotta S, Lentini S. In patients undergoing surgical repair of post-infarction ventricular septal defect, does concomitant revascularization improve prognosis? Interact Cardiovasc Thorac Surg. 2009 Nov;9(5):879-87.Full text  Abstract

33. Landzberg MJ, Lock JE. Transcatheter management of ventricular septal rupture after myocardial infarction. Semin Thorac Cardiovasc Surg. 1998 Apr;10(2):128-32. Abstract

34. Pesonen E, Thilen U, Sandstrom S, et al. Transcatheter closure of post-infarction ventricular septal defect with the Amplatzer Septal Occluder device. Scand Cardiovasc J. 2000 Aug;34(4):446-8. Abstract

35. Gabriel HM, Heger M, Innerhofer P, et al. Long-term outcome of patients with ventricular septal defect considered not to require surgical closure during childhood. J Am Coll Cardiol. 2002 Mar 20;39(6):1066-71. Abstract

36. Gatzoulis MA, Beghetti M, Galiè N, et al. Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension study. Int J Cardiol. 2008 Jun 23;127(1):27-32. Abstract

37. Galiè N, Humbert M, Vachiery J-L, et al; ESC Scientific Document Group. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT) Eur Heart J . 2016 Jan 1;37(1):67-119.Full text  Abstract

38. Pienvichit P, Piemonte TC. Percutaneous closure of postmyocardial infarction ventricular septal defect with the CardioSEAL septal occluder implant. Catheter Cardiovasc Interv. 2001 Dec;54(4):490-4. Abstract

39. Ogino H, Miki S, Ueda Y, et al. Surgical management of aortic regurgitation associated with ventricular septal defect. J Heart Valve Dis. 1997 Mar;6(2):174-8. Abstract

40. Predescu D, Chaturvedi RR, Friedberg MK, et al. Complete heart block associated with device closure of perimembranous ventricular septal defects. J Thorac Cardiovasc Surg. 2008 Nov;136(5):1223-8. Abstract

41. Mylonakis E, Calderwood SB. Medical progress: infective endocarditis in adults. N Engl J Med. 2001 Nov 1;345(18):1318-30. Abstract

Use of this content is subject to our disclaimer